Hanyang Yu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Hanyang Yu has a total of 127 co-authors. Here are the top co-authors by number of shared publications:
- Zhe Li
State Key Laboratory of Analytical Chemistry for Life Science Department of Biomedical Engineering College of Engineering and Applied Sciences Nanjing University Nanjing Jiangsu 210023 P. R. China
18 shared publications Yueyao Wang
State Key Laboratory of Coordination Chemistry, Department of Biomedical Engineering, College of Engineering and Applied Sciences, Chemistry and Biomedicine Innovation Center (ChemBIC), ChemBioMed Interdisciplinary Research Center at Nanjing University, Nanjing University, Nanjing, China
9 shared publicationsJintao Yang
State Key Laboratory of Coordination Chemistry, Department of Biomedical Engineering, College of Engineering and Applied Sciences, Chemistry and Biomedicine Innovation Center (ChemBIC), Jiangsu Key Laboratory of Artificial Functional Materials, Nanjing University, Nanjing 210023, China
8 shared publicationsJuan Wang
Department of Laboratory Medicine, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School Nanjing University Nanjing Jiangsu China
8 shared publicationsYao Wang
State Key Laboratory of Coordination Chemistry, Department of Biomedical Engineering, College of Engineering and Applied Sciences, Chemistry and Biomedicine Innovation Center (ChemBIC), ChemBioMed Interdisciplinary Research Center at Nanjing University
7 shared publications- Ze Zhang
State Key Laboratory of Coordination Chemistry Department of Biomedical Engineering College of Engineering and Applied Sciences Chemistry and Biomedicine Innovation Center (ChemBIC) Jiangsu Key Laboratory of Artificial Functional Materials Nanjing University Nanjing Jiangsu 210023 China
6 shared publications
Latest Publications
- Open Access
- 11 September 2026
- Published by Springer Nature in Science China Chemistry
- Vol. 69 (11) , 6000-6003
Empowering DNA nanotechnology with xeno-nucleic acids
- 11 September 2026
- Published by Springer Nature in Science China Chemistry
- Vol. 69 (11) , 6000-6003
Open AccessEmpowering DNA nanotechnology with xeno-nucleic acids
- Open Access
Chemically Modified DNAzyme with Enhanced Activity for Sensitive MicroRNA Imaging in Live Cells
As critical regulators of gene expression, microRNAs (miRNAs) are key biomarkers and therapeutic targets in cancer. However, current methods for intracellular miRNA imaging are often limited by poor sensitivity and operational complexity. In this study, we identified a site-specifically modified DNAzyme variant, 11Bn, which exhibits up to 7-fold higher catalytic activity than the wild-type 8-17 through systematic screening. Using this variant, we constructed a DNAzyme-based sensor for miRNA-21 imaging in living cells. The sensor achieves a limit of detection of 7.89 nM, threefold lower than that of the wild-type sensor, and enables sensitive visualization of intracellular miRNA-21 without signal amplification. Moreover, it can capture dynamic changes in miRNA levels within cells, providing a versatile molecular tool for miRNA imaging and related biomedical applications.
Open AccessChemically Modified DNAzyme with Enhanced Activity for Sensitive MicroRNA Imaging in Live Cells
As critical regulators of gene expression, microRNAs (miRNAs) are key biomarkers and therapeutic targets in cancer. However, current methods for intracellular miRNA imaging are often limited by poor sensitivity and operational complexity. In this study, we identified a site-specifically modified DNAzyme variant, 11Bn, which exhibits up to 7-fold higher catalytic activity than the wild-type 8-17 through systematic screening. Using this variant, we constructed a DNAzyme-based sensor for miRNA-21 imaging in living cells. The sensor achieves a limit of detection of 7.89 nM, threefold lower than that of the wild-type sensor, and enables sensitive visualization of intracellular miRNA-21 without signal amplification. Moreover, it can capture dynamic changes in miRNA levels within cells, providing a versatile molecular tool for miRNA imaging and related biomedical applications.
- 20 January 2026
- Published by Wiley in Angewandte Chemie
- Vol. 138 (9)
Sanger Sequencing of Xeno‐Nucleic Acid
Xeno‐nucleic acids (XNAs) offer biostable genetic polymers for biotechnology and information technology, but are incompatible with prevailing DNA sequencing methodologies. Here we report a Sanger sequencing approach tailored for XNA, enabling direct readout of XNA strands up to 50 bases. This new method relies on a Bst DNA polymerase mutant, which not only recognizes XNA as a template but also efficiently incorporates dideoxyribonucleoside triphosphate (ddNTP) substrates, facilitating sequencing of XNA by synthesis of complementary DNA. The Bst F710Y mutant exhibits at least two orders of magnitude higher activity in catalyzing ddNTP incorporation. Our method demonstrates accurate sequence determination of diverse XNA strands of distinct backbone chemistries such as TNA and FANA. Lastly, we showcase proof‐of‐concept automated XNA sequencing on a genetic analyzer instrument, by leveraging Bst mutant's ability to stochastically incorporate BigDye‐labeled ddNTP substrates in a single reaction. This work establishes a direct sequencing platform for XNA employing a chain termination strategy, and lays a foundation for future de novo identification of functional XNA and development of XNA‐based data storage system.
- 20 January 2026
- Published by Wiley in Angewandte Chemie
- Vol. 138 (9)
Sanger Sequencing of Xeno‐Nucleic Acid
Xeno‐nucleic acids (XNAs) offer biostable genetic polymers for biotechnology and information technology, but are incompatible with prevailing DNA sequencing methodologies. Here we report a Sanger sequencing approach tailored for XNA, enabling direct readout of XNA strands up to 50 bases. This new method relies on a Bst DNA polymerase mutant, which not only recognizes XNA as a template but also efficiently incorporates dideoxyribonucleoside triphosphate (ddNTP) substrates, facilitating sequencing of XNA by synthesis of complementary DNA. The Bst F710Y mutant exhibits at least two orders of magnitude higher activity in catalyzing ddNTP incorporation. Our method demonstrates accurate sequence determination of diverse XNA strands of distinct backbone chemistries such as TNA and FANA. Lastly, we showcase proof‐of‐concept automated XNA sequencing on a genetic analyzer instrument, by leveraging Bst mutant's ability to stochastically incorporate BigDye‐labeled ddNTP substrates in a single reaction. This work establishes a direct sequencing platform for XNA employing a chain termination strategy, and lays a foundation for future de novo identification of functional XNA and development of XNA‐based data storage system.
- 20 January 2026
- Published by Wiley in Angewandte Chemie International Edition
- Vol. 65 (9) , e16617
Sanger Sequencing of Xeno‐Nucleic Acid
Xeno‐nucleic acids (XNAs) offer biostable genetic polymers for biotechnology and information technology, but are incompatible with prevailing DNA sequencing methodologies. Here we report a Sanger sequencing approach tailored for XNA, enabling direct readout of XNA strands up to 50 bases. This new method relies on a Bst DNA polymerase mutant, which not only recognizes XNA as a template but also efficiently incorporates dideoxyribonucleoside triphosphate (ddNTP) substrates, facilitating sequencing of XNA by synthesis of complementary DNA. The Bst F710Y mutant exhibits at least two orders of magnitude higher activity in catalyzing ddNTP incorporation. Our method demonstrates accurate sequence determination of diverse XNA strands of distinct backbone chemistries such as TNA and FANA. Lastly, we showcase proof‐of‐concept automated XNA sequencing on a genetic analyzer instrument, by leveraging Bst mutant's ability to stochastically incorporate BigDye‐labeled ddNTP substrates in a single reaction. This work establishes a direct sequencing platform for XNA employing a chain termination strategy, and lays a foundation for future de novo identification of functional XNA and development of XNA‐based data storage system.
- 20 January 2026
- Published by Wiley in Angewandte Chemie International Edition
- Vol. 65 (9) , e16617
Sanger Sequencing of Xeno‐Nucleic Acid
Xeno‐nucleic acids (XNAs) offer biostable genetic polymers for biotechnology and information technology, but are incompatible with prevailing DNA sequencing methodologies. Here we report a Sanger sequencing approach tailored for XNA, enabling direct readout of XNA strands up to 50 bases. This new method relies on a Bst DNA polymerase mutant, which not only recognizes XNA as a template but also efficiently incorporates dideoxyribonucleoside triphosphate (ddNTP) substrates, facilitating sequencing of XNA by synthesis of complementary DNA. The Bst F710Y mutant exhibits at least two orders of magnitude higher activity in catalyzing ddNTP incorporation. Our method demonstrates accurate sequence determination of diverse XNA strands of distinct backbone chemistries such as TNA and FANA. Lastly, we showcase proof‐of‐concept automated XNA sequencing on a genetic analyzer instrument, by leveraging Bst mutant's ability to stochastically incorporate BigDye‐labeled ddNTP substrates in a single reaction. This work establishes a direct sequencing platform for XNA employing a chain termination strategy, and lays a foundation for future de novo identification of functional XNA and development of XNA‐based data storage system.
- 25 November 2025
- Published by Wiley in Current Protocols
- Vol. 5 (11) , e70261
In Vitro Selection of Threose Nucleic Acid (TNA) Enzymes That Catalyze RNA Transformations
This article provides a comprehensive set of protocols for the in vitro selection of threose nucleic acid (TNA) enzymes capable of catalyzing RNA cleavage or ligation reactions. The article first outlines the generation of random‐sequence TNA libraries (typically comprising ∼10 14 unique molecules) covalently attached to their RNA substrates via engineered DNA polymerases. It then describes the procedure for isolating catalytically active TNA sequences through affinity chromatography or gel electrophoresis. These sequences are subsequently reverse‐transcribed to cDNA for amplification or sequencing. This set of protocols is primarily designed for selecting RNA‐cleaving and RNA ligase TNA enzymes but can be adapted for the discovery of TNA enzymes that act on DNA substrates or enzymes derived from other xeno‐nucleic acids, provided that requisite nucleoside triphosphates and compatible tool enzymes are available.© 2025 Wiley Periodicals LLC. Basic Protocol 1 : TNA library synthesis Basic Protocol 2 : Selection of RNA‐cleaving TNA enzyme Alternate Protocol : Selection of RNA ligase TNA enzyme Basic Protocol 3 : Reverse transcription of enriched TNA library Basic Protocol 4 : Preparation of template DNA for the next round
- 25 November 2025
- Published by Wiley in Current Protocols
- Vol. 5 (11) , e70261
In Vitro Selection of Threose Nucleic Acid (TNA) Enzymes That Catalyze RNA Transformations
This article provides a comprehensive set of protocols for the in vitro selection of threose nucleic acid (TNA) enzymes capable of catalyzing RNA cleavage or ligation reactions. The article first outlines the generation of random‐sequence TNA libraries (typically comprising ∼10 14 unique molecules) covalently attached to their RNA substrates via engineered DNA polymerases. It then describes the procedure for isolating catalytically active TNA sequences through affinity chromatography or gel electrophoresis. These sequences are subsequently reverse‐transcribed to cDNA for amplification or sequencing. This set of protocols is primarily designed for selecting RNA‐cleaving and RNA ligase TNA enzymes but can be adapted for the discovery of TNA enzymes that act on DNA substrates or enzymes derived from other xeno‐nucleic acids, provided that requisite nucleoside triphosphates and compatible tool enzymes are available.© 2025 Wiley Periodicals LLC. Basic Protocol 1 : TNA library synthesis Basic Protocol 2 : Selection of RNA‐cleaving TNA enzyme Alternate Protocol : Selection of RNA ligase TNA enzyme Basic Protocol 3 : Reverse transcription of enriched TNA library Basic Protocol 4 : Preparation of template DNA for the next round
- 21 July 2025
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 68 (19) , 19971-19983
Novel Aptamer-Drug Conjugate for Targeted Therapy in Triple-Negative Breast Cancer
Triple-negative breast cancer (TNBC) is a highly aggressive malignancy lacking targeted therapeutic modalities. Aptamers are promising targeting agents with high specificity and affinity. In this study, we identified a chemically modified nucleic acid aptamer (AptT1) that specifically recognized and internalized into TNBC cells. Mechanistic studies revealed that ANXA2 was an essential protein in facilitating AptT1 internalization via clathrin-mediated endocytosis. Furthermore, we constructed an aptamer-drug conjugate (ApDC) to selectively deliver a cytotoxic agent (SN38) to TNBC cells and demonstrated significant efficacy and safety in a TNBC xenograft model. These findings suggest that AptT1-based ApDC holds great potential as an innovative targeted strategy for TNBC.
- 21 July 2025
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 68 (19) , 19971-19983
Novel Aptamer-Drug Conjugate for Targeted Therapy in Triple-Negative Breast Cancer
Triple-negative breast cancer (TNBC) is a highly aggressive malignancy lacking targeted therapeutic modalities. Aptamers are promising targeting agents with high specificity and affinity. In this study, we identified a chemically modified nucleic acid aptamer (AptT1) that specifically recognized and internalized into TNBC cells. Mechanistic studies revealed that ANXA2 was an essential protein in facilitating AptT1 internalization via clathrin-mediated endocytosis. Furthermore, we constructed an aptamer-drug conjugate (ApDC) to selectively deliver a cytotoxic agent (SN38) to TNBC cells and demonstrated significant efficacy and safety in a TNBC xenograft model. These findings suggest that AptT1-based ApDC holds great potential as an innovative targeted strategy for TNBC.
- 15 May 2025
- Published by American Chemical Society (ACS) in Journal of the American Chemical Society
- Vol. 147 (21) , 18349-18358
A Threose Nucleic Acid (TNA) Enzyme Catalyzing Native 3′-5′ Ligation of RNA
Threose nucleic acid (TNA) is a synthetic genetic polymer of both prebiotic significance and practical utility. Identification of TNA molecules with enzymatic activities (TNAzymes) not only lends experimental support for TNA as a potential primitive catalyst but also offers intrinsically stable biotechnological and biomedical molecular tools. Here, we report the in vitro selection of TNAzymes capable of catalyzing the native 3'-5' ligation of two RNA oligonucleotides. The Zn2+-dependent TNAzyme facilitates the formation of a canonical phosphoester bond between a terminal 3'-hydroxyl group on one substrate and a 5'-triphosphate on the other. Under optimal conditions (pH 7.3 and 23 °C), the TNAzyme exhibits a catalytic rate constant of 0.39 h-1. Lastly, we demonstrate that the TNAzyme-catalyzed ligation of two RNA fragments could yield a functional RNA product such as a ribozyme. These findings showcase the potential role of TNA as a primordial catalyst during the emergence of the RNA world, as well as its prospective application in RNA synthesis.
- 15 May 2025
- Published by American Chemical Society (ACS) in Journal of the American Chemical Society
- Vol. 147 (21) , 18349-18358
A Threose Nucleic Acid (TNA) Enzyme Catalyzing Native 3′-5′ Ligation of RNA
Threose nucleic acid (TNA) is a synthetic genetic polymer of both prebiotic significance and practical utility. Identification of TNA molecules with enzymatic activities (TNAzymes) not only lends experimental support for TNA as a potential primitive catalyst but also offers intrinsically stable biotechnological and biomedical molecular tools. Here, we report the in vitro selection of TNAzymes capable of catalyzing the native 3'-5' ligation of two RNA oligonucleotides. The Zn2+-dependent TNAzyme facilitates the formation of a canonical phosphoester bond between a terminal 3'-hydroxyl group on one substrate and a 5'-triphosphate on the other. Under optimal conditions (pH 7.3 and 23 °C), the TNAzyme exhibits a catalytic rate constant of 0.39 h-1. Lastly, we demonstrate that the TNAzyme-catalyzed ligation of two RNA fragments could yield a functional RNA product such as a ribozyme. These findings showcase the potential role of TNA as a primordial catalyst during the emergence of the RNA world, as well as its prospective application in RNA synthesis.
- Open Access
- 5 February 2025
- Published by Elsevier in Molecular Therapy
- Vol. 33 (4) , 1552-1565
Converting TCR-based chimeric antigen receptor STAR into dual-specific targeting receptor for cancer immunotherapy
- 5 February 2025
- Published by Elsevier in Molecular Therapy
- Vol. 33 (4) , 1552-1565
Open AccessConverting TCR-based chimeric antigen receptor STAR into dual-specific targeting receptor for cancer immunotherapy
- 9 January 2025
- Published by Wiley in Angewandte Chemie
- Vol. 137 (11)
Spatially Preorganized Hybridization Chain Reaction for the Prompt Diagnosis of Inflammation
Biological systems utilize precise spatial organization to facilitate and regulate information transmission within signaling networks. Inspired by this, artificial scaffolds that enable delicate spatial arrangements are desirable to increase the local concentration of reactants, expedite specific interactions, and minimize undesired interference. In this study, we presented an integrated biosensing nanodevice, termed TRI‐HCR, in which hybridization chain reaction (HCR) probes were precisely organized on a triangular DNA origami nanostructure (TRI) with finely‐tuned distance, quantity, and pattern. Compared to traditional HCR in the free form, this nanodevice demonstrated increased reaction rate and signal level. We further employed the optimized TRI‐HCR for in vivo imaging of a nucleic acid biomarker of inflammatory diseases. In both acute gouty arthritis (AGA) and sepsis‐associated acute kidney injury (SA‐AKI) model mice, TRI‐HCR was capable of diagnosing inflammation in the early stages, significantly earlier than histological examination. We anticipate that this precise spatial preorganization strategy for HCR holds promise for broader applications in early disease detection and monitoring.
- 9 January 2025
- Published by Wiley in Angewandte Chemie
- Vol. 137 (11)
Spatially Preorganized Hybridization Chain Reaction for the Prompt Diagnosis of Inflammation
Biological systems utilize precise spatial organization to facilitate and regulate information transmission within signaling networks. Inspired by this, artificial scaffolds that enable delicate spatial arrangements are desirable to increase the local concentration of reactants, expedite specific interactions, and minimize undesired interference. In this study, we presented an integrated biosensing nanodevice, termed TRI‐HCR, in which hybridization chain reaction (HCR) probes were precisely organized on a triangular DNA origami nanostructure (TRI) with finely‐tuned distance, quantity, and pattern. Compared to traditional HCR in the free form, this nanodevice demonstrated increased reaction rate and signal level. We further employed the optimized TRI‐HCR for in vivo imaging of a nucleic acid biomarker of inflammatory diseases. In both acute gouty arthritis (AGA) and sepsis‐associated acute kidney injury (SA‐AKI) model mice, TRI‐HCR was capable of diagnosing inflammation in the early stages, significantly earlier than histological examination. We anticipate that this precise spatial preorganization strategy for HCR holds promise for broader applications in early disease detection and monitoring.
- 9 January 2025
- Published by Wiley in Angewandte Chemie International Edition
- Vol. 64 (11) , e202421022
Spatially Preorganized Hybridization Chain Reaction for the Prompt Diagnosis of Inflammation
Biological systems utilize precise spatial organization to facilitate and regulate information transmission within signaling networks. Inspired by this, artificial scaffolds that enable delicate spatial arrangements are desirable to increase the local concentration of reactants, expedite specific interactions, and minimize undesired interference. In this study, we presented an integrated biosensing nanodevice, termed TRI‐HCR, in which hybridization chain reaction (HCR) probes were precisely organized on a triangular DNA origami nanostructure (TRI) with finely‐tuned distance, quantity, and pattern. Compared to traditional HCR in the free form, this nanodevice demonstrated increased reaction rate and signal level. We further employed the optimized TRI‐HCR for in vivo imaging of a nucleic acid biomarker of inflammatory diseases. In both acute gouty arthritis (AGA) and sepsis‐associated acute kidney injury (SA‐AKI) model mice, TRI‐HCR was capable of diagnosing inflammation in the early stages, significantly earlier than histological examination. We anticipate that this precise spatial preorganization strategy for HCR holds promise for broader applications in early disease detection and monitoring.
- 9 January 2025
- Published by Wiley in Angewandte Chemie International Edition
- Vol. 64 (11) , e202421022
Spatially Preorganized Hybridization Chain Reaction for the Prompt Diagnosis of Inflammation
Biological systems utilize precise spatial organization to facilitate and regulate information transmission within signaling networks. Inspired by this, artificial scaffolds that enable delicate spatial arrangements are desirable to increase the local concentration of reactants, expedite specific interactions, and minimize undesired interference. In this study, we presented an integrated biosensing nanodevice, termed TRI‐HCR, in which hybridization chain reaction (HCR) probes were precisely organized on a triangular DNA origami nanostructure (TRI) with finely‐tuned distance, quantity, and pattern. Compared to traditional HCR in the free form, this nanodevice demonstrated increased reaction rate and signal level. We further employed the optimized TRI‐HCR for in vivo imaging of a nucleic acid biomarker of inflammatory diseases. In both acute gouty arthritis (AGA) and sepsis‐associated acute kidney injury (SA‐AKI) model mice, TRI‐HCR was capable of diagnosing inflammation in the early stages, significantly earlier than histological examination. We anticipate that this precise spatial preorganization strategy for HCR holds promise for broader applications in early disease detection and monitoring.